Atlas Trials

Expanded Access to Fosmanogepix for Patients With Serious or Life-threatening Invasive Fungal Infections

Clinical trial NCT06433128 · AVAILABLE

Trial details

NCT number
NCT06433128
Sponsor
Basilea Pharmaceutica
Status
AVAILABLE
Study type
EXPANDED_ACCESS
Invasive Fungal Infections

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.